RANZCO has partnered with the Australian Dyslexia Association (ADA) in an effort to demystify dyslexia – and thereby ensure children get the correct support in a timely manner – as part of Dyslexia Awareness Week (4-10 October). Read more
Beovu AMD therapy now listed on the PBS
Almost 13,000 Australians could save thousands annually with the Pharmaceutical Benefits Scheme (PBS) listing of Beovu (brolucizumab) for neovascular age-related macular degeneration (nAMD) from this month, the Federal Government says. Read more
RANZCO’s ‘The Tick’ to promote greater female inclusion
RANZCO has demonstrated its commitment to gender diversity, with the launch of a new initiative endorsing events that aim for higher levels of female representation. Read more
Hoya unveils new Hi-Vision SUN Pro Coating to local market
Hoya Vision Care Australia & New Zealand has announced the launch of its new Hi-Vision SUN Pro lens coating which provides both front and back protection against the sun’s ultraviolet (UV) rays. Read more
Hoya launches new anti-bacterial spectacle lens coating in ANZ
Hoya Vision Care Australia & New Zealand has introduced a new Hi-Vision Anti-Bacterial lens coating which the company says is proven to reduce bacterial growth on the surface of a lens by 99.9%. Read more
Ikervis ciclosporin eye drop now PBS-listed
Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin eye drop for severe keratitis in adults with dry eye disease (DED).
SILMO to make APAC comeback
After coming and going from the Australian conference calendar, the SILMO global eyewear and lifestyle trade show is set to return to the Asia-Pacific region in 2023 with the launch of a Singapore event. Read more
1 in 4 Australians not wearing sunglasses, research shows
Nearly a quarter (24%) of Australians, the equivalent of six million people, rarely or never wear sunglasses when outside during the day, according to new research commissioned by Specsavers. Read more
Silverstone’s optomap-guided OCT improves patient management
Two recent studies have demonstrated the Optos Silverstone device – combining ultra-widefield (UWF) fundus capture with optomap-guided swept source-OCT (SS-OCT) – can improve patient management and impact treatment decisions. Read more
Date changes for O=PEN HOUSE events
The O=PEN HOUSE multi-state equipment showcase convened by four of Australia’s leading ophthalmic equipment suppliers has pivoted to accommodate changing COVID-19 restrictions in NSW and Victoria. Read more